Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
-
SciScore for 10.1101/2020.06.14.149153: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication Contamination: All cell lines were regularly tested for mycoplasma contamination by sequencing from GATC Biotech (Germany). Table 2: Resources
Antibodies Sentences Resources (Gene Tex) and Rabbit anti-Vinculin #13901 (E1E9V XP®) ( anti-Vinculinsuggested: (Cell Signaling Technology Cat# 13901, RRID:AB_2728768)Experimental Models: Cell Lines Sentences Resources Viral replication Assay: Vero E6 cells expressing hTMPRSS2 were a kind gift of Makoto Takeda (University of Tokyo, Japan), and were cultured in DMEM (Lonza) … SciScore for 10.1101/2020.06.14.149153: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication Contamination: All cell lines were regularly tested for mycoplasma contamination by sequencing from GATC Biotech (Germany). Table 2: Resources
Antibodies Sentences Resources (Gene Tex) and Rabbit anti-Vinculin #13901 (E1E9V XP®) ( anti-Vinculinsuggested: (Cell Signaling Technology Cat# 13901, RRID:AB_2728768)Experimental Models: Cell Lines Sentences Resources Viral replication Assay: Vero E6 cells expressing hTMPRSS2 were a kind gift of Makoto Takeda (University of Tokyo, Japan), and were cultured in DMEM (Lonza) supplemented with 10% heat inactivated fetal calf serum, 200 IU/mL penicillin, 100 μg/mL streptomycin, 600 μg/mL glutamine and 10 μg/mL blasticidin. Vero E6suggested: RRID:CVCL_XD71)The virus was propagated in Vero-hTMPRSS2 cells. Vero-hTMPRSS2suggested: None3 Western blot analysis: Vero E6 hTMPRSS2 cells infected with SARS-Cov-2 were lysed and analyzed by Western blot as done in with Rabbit Anti-SARS CoV-2 (COVID-19) Spike (Cat No. GTX135356) Vero E6 hTMPRSS2suggested: NoneSoftware and Algorithms Sentences Resources Cells with condensed chromatin were counted in CellProfiler 3.1.9. CellProfilersuggested: NoneThe count for the 8 sites each well was summed, all wells were subtracted the mean count from uninfected wells (10 wells), normalized to DMSO/media treated cells and fitted to a 4-parameter nonlinear regression in Prism 8.3.0 for Windows, GraphPad Software, La Jolla California USA, Prismsuggested: (PRISM, RRID:SCR_005375)Data was subtracted background (CellTiter blue in media, no cells) normalized to DMSO/media treated cells and fitted to a 4-parameter nonlinear regression in Prism 8.3.0 for Windows, GraphPad Software, La Jolla California USA, GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-